The National Center for Tumour Diseases (NCT), University Hospital Heidelberg, is an internationally recognised centre of excellence for the treatment of cancers of all types. The Center combines comprehensive, interdisciplinary patient care with cutting-edge cancer research under one roof.
The NCT works very closely with the renowned German Cancer Research Center (DKFZ, one of Germany's major research institutions). The participating specialists at the 22 specialist clinics are all very experienced medical practitioners who have extensive knowledge in the application of proven methods and the latest innovative treatment options in their respective fields. They are also directly involved in the development of new therapeutic approaches in personalised cancer medicine.
Helsana policyholders suffering from tumour diseases can seek a second opinion from the NCT. A dedicated, highly qualified team of experts is available for all types of tumour disease. In weekly meetings, known as tumour boards, they discuss individual patient cases. At these meetings, all relevant factors in treating the cancer are considered in a multi-disciplinary approach. Patients receive an individualised treatment recommendation and on request additional consultations.
Benefits for Helsana Group policyholders at the Martini-Klinik
- Second opinion by an interdisciplinary team of experts at an international centre of excellence
- No need to individually consult different specialists
- Interdisciplinary and individualised treatment recommendations
- On request, other comprehensive consultation opportunities regarding diet, exercise and cancer